Sector pending / Pharmaceutical PreparationsUpdated 2026-05-10 22:07 UTC

BIT/1MDGL stock hub

BIT/1MDGL has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BIT/1MDGLis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

10B

Borsa Italiana

Market data

Live price

Current market quote for this ticker.

Current price

BIT/1MDGL

In the news

Latest news · BIT/1MDGL

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-49.3

P25 n/aP50 n/aP75 n/a

ROIC-22.8

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BIT/1MDGL market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

157

Groups with data

Currency

USD

Showing 157 of 157 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	IT
Employees	915
Employees Change	387%
Employees Change Percent	73.3
Enterprise value	EUR 9.6B
Exchange	Borsa Italiana
Financial currency	USD
First seen	2026-05-10
Industry	Pharmaceutical Preparations
Last refreshed	2026-05-10
Market cap	EUR 10B
Price	EUR 451
Price currency	EUR
Rev Per Employee	1,073,452x
Sic	2834
Symbol	bit/1MDGL
Website	https://www.madrigalpharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-2.69%
EV Earnings	-35.75x
EV/FCF	-40.61x
EV/Sales	9.97x
FCF yield	-2.36%
P/B ratio	21.2x
P/S ratio	10.17x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-27.68%
EBITDA Margin	-27.55%
Gross margin	93.07%
Gross Profit	EUR 914.1M
Gross Profit Growth	243.73%
Gross Profit Growth Q	114.33%
Net Income	EUR -268.4M
Pretax Margin	-27.32%
Profit Margin	-27.32%
Profit Per Employee	EUR -293,306
ROA	-17.62
Roa5y	-42.5
ROCE	-35.26
ROE	-49.35
Roe5y	-101.6
ROIC	-22.77

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	75.3%
Revenue Growth	256.82x
Revenue Growth Q	126.84x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 1.02
Assets	EUR 1.1B
Cash	EUR 704.9M
Current Assets	EUR 1B
Current Liabilities	EUR 286.8M
Debt	EUR 301.2M
Debt Equity	EUR 0.64
Debt FCF	EUR -1.27
Equity	EUR 471.3M
Interest Coverage	-11.68
Liabilities	EUR 593.1M
Long Term Assets	EUR 61.9M
Long Term Liabilities	EUR 306.3M
Net Cash	EUR 403.7M
Net Cash By Market Cap	EUR 4.04
Net Cash Growth	-35.65%
Net Debt Equity	EUR -0.86
Tangible Book Value	EUR 465M
Tangible Book Value Per Share	EUR 20.18

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.5
Inventory Turnover	0.94
Net Working Capital	EUR 28.6M
Quick ratio	2.96
Working Capital	EUR 732M
Working Capital Turnover	EUR 1.18

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	2.67%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	75.23%
200-day SMA	403.2
50-day SMA	417.2
50-day SMA vs 200-day SMA	50over200
All Time High	518.2
All Time High Change	-13.03%
All Time High Date	2025-11-27
All Time Low	237.5
All Time Low Change	89.77%
All Time Low Date	2025-05-29
ATR	7.52
Ch YTD	-8.69
High	450.7
High52	518.2
High52 Date	2025-11-27
High52ch	-13.03%
Low	449.4
Low52	237.5
Low52 Date	2025-05-29
Low52ch	89.77%
Ma50ch	8.02%
Price vs 200-day SMA	11.77%
RSI	51.92
RSI Monthly	0
RSI Weekly	58.53
Sharpe ratio	1.27x
Sortino ratio	2.16
Total Return	2.67%
Tr YTD	-8.69
Tr1m	3.04%
Tr1w	1.3%
Tr3m	11.86%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR -271.9M
Operating margin	-27.68

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	12,606,538%
Net Borrowing	193,620,251.2
Shares Insiders	8.43%
Shares Institutions	69.89%
Shares Qo Q	27.17%
Shares Yo Y	-2.67%
Short Ratio	11.49

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR -332.7M
Average Volume	1.15x
Bv Per Share	20.46
CAPEX	EUR -3.7M
Ch1m	3.04
Ch1w	1.3
Ch1y	75.23
Ch3m	11.86
Ch6m	7.93
Change	2.08%
Change From Open	0.29
Close	441.5
Days Gap	1.79
Depreciation Amortization	1,282,966.5
Dollar Volume	7,211.2
Earnings Date	2026-05-06
EBIT	EUR -271.9M
EBITDA	EUR -270.6M
EPS	EUR -11.84
F Score	2
FCF	EUR -236.3M
FCF EV Yield	-2.46x
Financing CF	216,541,393
Fiscal Year End	December
Founded	2,016
Investing CF	52,587,001
Is Primary Listing	0
Last Earnings Date	2026-05-06
Last Report Date	2026-03-31
Ma150	426.5
Ma150ch	5.68%
Ma20	444.7
Ma20ch	1.34%
Net CF	37,763,977
Open	449.4
Position In Range	100
Ppne	12,073,283
Price Date	2026-05-06
Ptbv Ratio	21.48
Relative Volume	11.03x
Revenue	982,208,577x
SBC By Revenue	9.82x
Share Based Comp	96,458,504
Tr6m	7.93%
Volume	16
Z Score	6.61

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does BIT/1MDGL pay a dividend?

Capital-return profile for this ticker.

Performance

BIT/1MDGL stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns BIT/1MDGL?

Insider, institutional, and short-interest positioning.

Institutional ownership

+69.9%

Share of float held by funds and institutions

Insider ownership

+8.4%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

BIT/1MDGL momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

51.9

Neutral momentum band

Price vs 200-day MA

+11.8%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

1.26

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BIT/1MDGL

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bit/1MDGL stock rating?

bit/1MDGL is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bit/1MDGL analysis?

The full report lives at /stocks/bit/1MDGL/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bit/1MDGL?

The latest report frames bit/1MDGL around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bit/1MDGL page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.